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CHAPTER fOURTEEN

Division of Rheumatology
NATHAN

M.

SMUKLER,

M.D.

"The rheumatism is a common name for
many aches and pains~ which have yet
got no peculiar appellation~ though
owing to very different causes.~~
-WILLIAM HEBERDEN (1710-1801)

s THE various subspecialties of internal
medicine evolved, rhewnatology developed
comparatively late. In the immediate
decades preceding and following World War II,
Departments of Medicine of United States medical
colleges generally adopted divisional or sectional
formats. During this organizational period
such established subspecialites as cardiology,
gastroenterology, and hematology took priority,
and at many institutions rheumatology was either
present on a very small scale or nonexistent. In the
I950S and 60S, however, there occurred a surge of
interest in rhewnatology, and this subspecialty
became an organized entity at many institutions.
Among the factors that contributed to this
rapid development of rheumatology were the
discovery of the antiinflammatory properties of
glucocorticoids by Hench and co-workers at the
Mayo Clinic, the explosion of new knowledge in
the field of immunology, the National Institutes of
Health research and training grants, and the trend
to subspecialization by internists during the post
World War II era.
At Jefferson the divisional organization of the
Deparunent of Medicine occurred during the

A

tenure of Dr. Robert 1. Wise as Chairman (1959
1975). In the forming of Divisions, rhewnatology
was among the last. Nevertheless, an arthritis
clinic was established at Jefferson Hospital in [931
and preceded the establishment of the Division by
28 years. Even before these events, a nwnber of
Jeffersonians made contributions to this specialty.

Early Rheumatology at Jefferson
In 1880, Roberts Bartholow, Professor of Materia
Medica, wrote an elegant detailed description of
the rhewnatic diseases that constituted a chapter
of his textbook Practice ofMedicine. Dr.
Bartholow was born in 1831, received his M.D.
degree from the University of Maryland, and was
a member of the active faculty at Jefferson from
1879 to 1891. He died in 1904. Teaching and clinic
activities at Jefferson did not deter him from
writing; his bibliography included numerous
articles and the sole authorship of a textbook of
therapeutics, as well as the one of medicine.
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Bartholows chapter devoted to rheumatism was
divided into discussions of acute and chronic joint
disease. The portion on acutc rheumatism was
entirely concerned with rheumatic fever, a disease
known also at the time as articular rheumatism
and polyarthritis rheumatica. In his clinical
description of the arthritis of rheumatic fever he
detailed its migratory course, the tendency to
involve large rather than small joints, and its
limited duration of four to six weeks. Also cited
was the propensity of those complicated with
carditis to develop chronic heart disease later in
life. Erythema marginatum and chorea were not
mentioned. Although the temporal relationship of
rhematic fever and scarlet fever was discussed,
there is no indication of appreciation that acute
pharyngitis frequently preceded this disease.
Bartholows lucid discussion of the differential
diagnosis of rheumatic fever is entirely valid after
the lapse of a century. It included pyaemia (septic
arthritis), rheumatoid arthritis, acute gout, urethral
rheumatism (gonococcal urethritis and Reiter's
syndrome), and hysterical joint disease. A variety
of treatment modalities were described, but only
salicylate is still in use. Salicylate was described as
being very effective, but its use caused
gastrointestinal complications, tinnitus, and
depression of the heart. Possibly the cardiotoxic
properties attributed to salicylate reflected the
carditis of rheumatic fever. However, the concept
that "aspirin is bad for the heart" persisted, and
many patients some 70 and 80 years later refused
aspirin for this reason.
In his discussion of chronic joint disease,
Bartholow presented three categories: chronic
rhetill1atisDl, gout, and arthritis deformans.
Chronic rheumatism was identified as a joint
disorder developing in patients beyond middle
age, marked by stiffness, particularly in the
morning, intermittent swelling, and rarely joint
inflan1ffiation. His "chronic rheumatism" appeared
to be that portion of the spectrum of arthritis that
is presently classified as osteoarthritis. It is of
interest, however, that he failed to touch upon a
key point of osteoarthritis, the predilection of the
disease to involve the distal joints of the fingers,
the hips, the knees, and the low spine.
Gout was classified as a chronic disease,
although the acute episodes of arthritis that may
precede or be superimposed upon the chronic
involvement were described in detai1. Bartholow
listed obesity and lead nephropathy (saturnine
gout) as factors that predispose to gout and
also discussed the association of gout and

atherosclerosis. Colchicine and salicylate were
advocated for the treatment of acute gouty
arthritis. After the passage of a century colchicine
is still utilized for treatment and prophylaxis of
this phase of gout. Also, today it is appreciated
that weight reduction may lower the serum uric
acid. Thus there is a rational basis for Bartholow's
empiric recommendation of a sparse diet featuring
fruits and vegetables and regular exercise in the
treatment of this disease.
The final group of patients presented in
Bartholows chronic rheumatism section were
those with destructive inflan1ffiation of multiple
joints. They were discussed under the heading of
arthritis deformans, which he favored over
"rheumatoid arthritis," the term coined by the
English physician Garrod to describe similar
patients. Bartholow's arthritis deformans patients
included those with limb joint involvement and
also those with rigidity of the spine. These
patients by present-day criteria would be
categorized as having rheumatoid arthritis and
ankylosing spondylitis, respectively.
In 1882, Morris Longstreth (184-6-1914-),
Professor of Pathological Anatomy at Jefferson,
authored a monograph concerned with rheumatic
diseases. Dr. Longstreth was born and raised in
the Philadelphia area and received an A.B. degree
from both Haverford and Harvard Colleges
and an M.D. degree from the University of
Pennsylvania. He became a Resident at the
Pennsylvania Hospital, where he developed an
interest in both pathology and the rheumatic
diseases. 2 After his residency he continued at the
Pennsylvania Hospital as Attending Physician and
Curator of the Pathological Museum. He was
appointed Professor of Pathological Anatomy at
JefIerson in 1879 and retained this position until
1895, when he resigned to enter private practice in
Philadelphia. The Willian1 Wood publishing firm
in New York City encouraged Dr. Longstreth to
make known his knowledge of the rheumatic
diseases and he responded with a monograph of
279 pages. 3
The first few chapters of Longstreth's text,
entitled Gout) Rheumatis1n and Some Allied

34-8 • Thomas Jefferson University

Disorders) were concerned with the spectrum of
rheumatic diseases, including etiology and
pathology. The middle and largest portion of the
volume was devoted to the clinical, laboratory,
and pathological aspects of rheumatic fever, which
at the time of publication was the most prevalent
of the acute rheumatic diseases. The emphasis on
rheumatic fever is of interest in that present-day
medical students are unlikely to encounter this
disease except in relation to residual valvular heart
disease.
Longstreth's chapter devoted to rheumatic fever
gave an excellent description of acute arthritis
associated with this disease. He and his
contemporaries had a good understanding of
rheumatic heart disease. They appreciated that
there was involvement of the pericardium,
myocardium, and endocardium. Although
auscultation permitted clinical detection of
endocarditis, the myocardial and pericardial disease
was generally demonstrated at postmortem
examination. Finally, it was clearly described that
some patients with acute endocarditis went on to
recovery, whereas others developed severe
progressive and ultimately fatal heart disease.
Longstreth noted that acute rheumatic fever was
more common among the poor than in those
from the higher economic classes, an observation
that was made again in this country some 50 years
later.
A chapter of Longstreth's book was devoted to
central nervous system complications of rheumatic
fever. He described neuropathological findings in
the meninges and brain and also neural symptoms
that were considered to reflect systemic aspects of
the disease such as fever. For example, he quoted
Dr. Jacob Mendes DaCosta of the Jefferson
faculty, who reported that a patient may develop
cerebral rheumatism during or shortly after an
attack of rheun1atic fever. 4 Cerebral rheumatism
was described as a restlessness passing into stupor,
coma, or delirium and terminating in death.
In some of these patients there were focal
neurological findings as seizures, palsies, or
hemiplegia. This material is difficult to reconcile
with present-day concepts of the central nervous

system involvement in rhematic fever, which is
limited to the basal ganglia, expressed as chorea.
In fairness to Longstreth it is to be noted he
indicated that the meninges and cerebral disease
described in these rheumatic fever patients may
have been due to a complicating disease such as
meningitis rather than the rheumatic fever. In
hindsight the "cerebral rheumatism" may have
represented systemic lupus erythematosus that was
not delineated from rheumatic fever, or even a
phase of rheumatic fever no longer encountered.
With respect to treatment, salicylate in various
forms was recommended as being effective in
management of the arthritis but not the carditis of
rheumatic fever. A quote from Longstretll
concerning salicylic acid is of interest in view
of tlle fact that many present-day physicians
favor salicylates over the other nonsteroidal
antiinflammatory drugs, as they are effective and
less expensive. "The acid (salicylic acid) has been
known since 1844 when it was prepared from oil
of wintergreen. Its scarcity and great cost
prevented its use and its quality remained to a
great degree unknown." He goes on to state that
in the ensuing years manufacturing techniques
improved, and the drug became less expensive.
Longstretll's last chapters were devoted to
chronic articular rheumatism (osteoarthritis), gout,
and gonorrheal arthritis. Of particular interest is
the description of the natural course of gonococcal
arthritis in the prepenicillin era. The attack of
arthritis might last for weeks or months, and in
some instances there was progression to chronic
effusion, fibrous involvement, and fibrous
ankylosis. In contrast to present-day rheumatology
textbooks, which give top priority to rheumatoid
arthritis, Dr. Longstreth was cursory in his
approach to this disease and considered it
primarily in subsections devoted to the differential
diagnosis of arthritis. Factors to be considered in
the rise in importance of rheumatoid arthritis over
the course of a century include the virtual
disappearance of rheumatic fever in the United
States and Western European countries, the
development of laboratory and radiographic
techniques that facilitate the delineation of
rheumatoid arthritis from other rheumatic diseases,
and possibly an increased prevalence of
rheumatoid arthritis in recent decades.
In 1886 representatives from Philadelphia
hospitals presented their treatment programs for
the rheumatic diseases. s Drs. J. M. DaCosta
and Bartholow represented Jefferson, and Dr.
Longstreth the Pennsylvania Hospital, although
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he also held a Professorship at Jefferson. The
renowned Dr. William Osler of the University of
PelU1sylvania Hospital and Dr. James Tyson of the
Philadelphia Hospital (Philadelphia General
Hospital) also contributed. The main focus on the
discussion was directed to rheumatic fever. It was
generally agreed that salicylatcs were useful in
controlling the articular but not the cardiac
manifestations. For joint pain, opium or one of its
derivatives was advocated both systemically and by
local application.
In 1914- Dr. Solomon Solis-Cohen (Figure 14--1)
(Jefferson, 1883), Professor of Clinical Medicine,
authored a paper6 that represented the first report
in the English literature of the rheumatic entity
now termed palindromic arthritis. It is an episodic
disorder marked by attacks of pain and swelling of
joints or tissues adjacent to joints, lasting for a day
or a few days, with variable intervals between
attacks. After months or years the attacks may
cease. At times, however, they may be a harbinger
of rheumatoid arthritis. Dr. Solis-Cohen's report
reviewed a series of patients, many of whom

manifested an episodic disorder consistent with
palindromic arthritis. He attributed the articular
and periarticular involvement to an autonomic
imbalance, which he termed vasomotor or
autonomic ataxia; however, at present this
condition is considered to reflect a disorder of the
immune system. He also published many
additional reports dealing with clinical features or
treatment of rheumatic disease.7- 9
Dr. Abraham Cohen (Figure 14--2) was one of
the pioneer rheumatologists in the United States.
Cohen (Jefferson, 1925) was a member of the staff
of Jefferson Hospital with special interest in its
arthritis clinic from 1931 lU1til his death in 1969. In
addition, he was active at the Philadelphia General
Hospital and headed an arthritis clinic at that
hospital for many years. Dr. Cohen's hospital
appointments and bibliography demonstrate his

FIG. 14--1. Solomon Solis-Cohen, M.D., Professor of

Clinical Medicine (1904--1927) and Jefferson pioneer in
treatment of "rheumatic disorders."

FIG. 14-2. Abraham Cohen, M.D., innovative organizer of
(1931).

Jefh:rson's first arthritis clinic
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Blizzard (Jefferson, 1954), and Leon Weiner
participated in the Jefferson Arthritis Clinic.

The Division of Rheunlatology
capacity as tireless worker, astute ob~erver, and
innovative therapist. In 1941 he published the first
defmitive description of gouty arthritis in black
Americans. 1O Before that time there was only one
case report of gout in a black American, which
had appeared in a Scandinavian journal. Cohen
also authored 20 additional papers on a vanety of
rheumatological topics. In the New Engl~nd
.
Journal ofMedicine) he det~iled his. eXPr~;Ience With
gold therapy for rheumatoid a.rthntls.' He also
reported a trial of an estrogemc s~~stance for
the treatment of rheumatoid arthntIs. Several
papers described his use of physostigmine and
neostigmine for patients with musculoskeletal
articular pain and muscle spasms, as well as
histamine for those with impaired peripheral
circulation.'3- '1 In the context of todays use of
such immunosuppressive agents as az.athi~prine
and methotrexate to manage connective tissue
diseases, Dr. Cohen's effort with a trial of .
nitrogen mustard for patients with rheumatOId
.
arthritis was prophetic. 1 6 .
From 1946 until 1956 Dr. Richard T. Smith
(Figure 14-3) (Jefferson, 1941) served as Chief of
the Rheumatology outpatient clinic. He was a
staunch advocate of gold therapy prior to the time
that this agent was unequivocally establishe? as an
effective therapeutic modality for rheumatoid
arthritis. Subsequent to his activity at Jefferson
Hospital, Dr. Smith was the ~ttendin~
Rheumatologist at Pennsylval1la Ho~pltal and also
was active at the Merck PharmaceutICal Company.
He died suddenly at age '58.
.
Dr. Irvin F. Hermann (Jefferson, 1937) aSSisted
Dr. Smith at the arthritis clinic. Dr. Hermann's
training included a fellowship with the eminent
.
rheumatologist, Dr. Walter Bauer, at th~
Massachusetts General Hospital. Followmg hIS
fellowship, Dr. Hermann returned to Philadelphia
and was active in rheumatology at Jefferson, at
Mt. Sinai Hospital of Philadelphia (the Southern
Division of the Albert Einstein Medical Center),
and at Pennsylvania Hospital. He later served as
Medical Director of the United States Postal
Service. In addition, Drs. Roy G. Hays, Edward
Mazur (Jefferson,' 1941), Howard Lorenz, John

A Division of Rheumatology within the
Department of Medicine was formed in July 1959,
with Nathan M. Smukler (Jefferson, 1947) as
Division Head. Dr. Smukler (Figure 14-4), who
had trained at the Mt. Sinai Hospital of
Philadelphia (now the Southern Division of the
Albert Einstein Medical Center) and In
rheumatology at the Hospital of the University of
Pennsylvania under Dr. Joseph Hollander, was a
member of the Department of Medicine a~ ~e
University of Pennsylvania School of MedICIne
before his appointment at Jefferson.
. ..
At the outset the only member of the DIVISIon
of Rheumatology beside Dr. Smukler was Howard
Lorenz, M.D., a volunteer faculty member who
attended the arthritis clinic. It was thus necessary
for Dr. Smuklcr to concentrate on teaching and
patient care activities and to pu~ aside temporarily
his research interests. The teachmg program
included bedside teaching rounds at Jefferson
Hospital, presentatio~1~ ofo~tpatients t? .stu~ents
assigned to the arthntls clIme, and partICIpatiOn at
medical grand rounds and formal lectures.
A particular interest of Dr. Smukler wa.s the
suspected role of psychological disorders m

FIG. 14-3. Richard T. Smith, M.D., early advocate of gold

therapy for rheumatoid arthritis.
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provoking, sustaining, or aggravating rheumatoid
arthritis and other systemic inflammatory
rhewnatic diseases. It was envisioned that a group
of psychologists, psychiatrists, and rhewnatologists
could be organized to investigate this
psychosomatic concept, and a request for support
was submitted to the National Institutes of
Health. Although this application was never
funded, Dr. Smukler continued his observations of
psychological factors upon the course of
rhewnatoid arthritis and other chronic rheumatic
diseases. Other areas of study included the
neuroanatomy and neurophysiology of pain,
nonorganic musculoskeletal-articular pain, systemic
vasculitis, and spinal arthritis.
Dr. John Abruzzo became the second full-time
member of the Division in February, 1967. Before
corning to Jefferson, Dr. Abruzzo (Figure 14--5), a
graduate of Georgetown University School of
Medicine, had been a resident in internal medicine
at the Jersey City Medical Center, a Fellow in
Rheumatology at the Columbia-Presbyterian
Medical Center in New York City, and faculty

FIG. J4-4. Nathan M. Smukler, M.D., Chief of the
Jefferson Rheumatology Division (1958-J980).

member with the rank of Assistant Professor of
Medicine at the New Jersey College of Medicine.
During his fellowship at the Columbia
Presbyterian Rheumatic Disease Unit under Dr.
Charles Christian, Dr. Abruzzo collaborated in a
study that showed that chronic injection of E. coli
into dogs induced rheumatoid factor. 17 This
pioneer work is among the factors that stimulated
intensive research directed to uncovering an
infectious etiology for rheumatoid arthritis. Mter
coming to Jefferson, Dr. Abruzzo engaged in
teaching, reorganized and directed the outpatient
center, and carried out clinical testing of
nonsteroidal antiinflammatory drugs in patients

FIG. 14-5. John 1" Abruzzo, M.D., Director, Division of
Rheumatology (J980- ).
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with rheumatoid arthritis and osteoarthritis. He
also collaborated with Dr. Ralph Heimer, a
member of the Department of Biochemistry, in
the study of alterations of serum proteins in
patients with various rheumatic diseases. In 1978
Abruzzo was named Associate Editor of the
Annals ofInternal Medicine. Dr. Abruzzo was
promoted to Associate Professor of Medicine in
1969 and to full Professor in 1974. He succeeded
Dr. Smukler as Head of the Division in 1980.
Dr. Ralph DeHoratius (Figure 14-6) (Jefferson,
1968) becan1e the third ful1-time member of the
Division in 1974. He had interned at Jefferson and
subsequently served a residency in internal
medicine and a fellowship in rheumatology at the

Ralph DeHoratius, M.D., explorer of
immunologic interrelationships in rheumatology.

FIG. 14-6.

University of New Mexico School of Medicine
under Dr. Ralph Williams. Following completion
of his training, Dr. DeHoratills joined the faculty
of the University of New Mexico School of
Medicine with the rank of Assistant Professor. At
the time, he also received a career development
award from the Veterans Administration, which
enabled him to pursue research concerning
pathogenetic immune mechanisms in connective
tissue diseases. A particular interest of Dr.
DeHoratius was detection of antibodies to
lympho<....ytes that are concerned with immune
regulatory mechanisms. He demonstrated their
presence in patients with systemic lupus
erythematosus, in their families and household
pets, and in laboratory workers exposed to their
blood. After returning to Jefferson as Assistant
Professor of Medicine, DeHoratius received a
young investigator award from the National
Institutes of Health to continue his studies of
defects in immune regulation in systemic lupus
erythematosus patients and their contacts. He also
developed an outpatient facility for evaluation
and treatment of systemic lupus erythematosus
patients. As a result of his productivity he rose to
the rank of full Professor in 1982. In that year
DeHoratius left Jefferson to accept a position as
Director of an Immunology and Rheumatology
Division in the Department of Medicine at
Halmemann Medical College.
During the 1950S and succeeding decades,
intensive investigation indicated that
immunological mechanisms contributed to the
pathogenesis and perhaps the etiology of
rheumatoid arthritis and other connective tissue
diseases. Consequently, immunologically oriented
research flourished at numerous rheumatology
units throughout the United States. In an effort to
facilitate this type of investigation at Jefferson, Dr.
Frank Gray, the Magee Professor of Medicine
(1976-1981), along with Drs. Abruzzo and
DeHoratius, recruited Dr. J. Bruce Smith to join
the Division in 1981. Dr. Smith, a graduate of the
Bowman Gray School of Medicine, had trained in
internal medicine at Pennsylvania Hospital and the
University of Pennsylvania Hospital. He then
became a Fellow in Immunology under Nobel
Laureate Dr. Baruch Blumberg at the Institute for
Cancer Research in Philadelphia and at University
College, London, England, under Dr. N. A.
Mitchison.
Following his training in immunology, Dr.
Smith was appointed a Research Physician at the
Institute for Cancer Research in Philadelphia (1974
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198I). During this period he received grants from
the American Cancer Society and the National
Institutes of Health for his studies of immune cell
interactions in laboratory aninnls, in normal
persons, and in patients with cancer. After joining
the Jefferson faculty, Dr. Smith expanded his
studies of immune ceU interactions to patients
with rheumatic diseases. His laboratory provided
research opportunities for Ph.D. investigators and
Fellows in Rhnunatology. Dr. Smith also
participated in all the clinical activities of the
Division.
To enhance further the expertise of the Division
in inununology, Dr. Willis Maddrey, who had
succeeded Dr. Frank Gray as Magee Professor of
Medicine in 1982, and Dr. Abruzw recruited Dr.
Henry Scovern. Dr. Scovern, a graduate of the
George Washington University School of
Medicine, had just completed a combined
fellowship in allergy, immunology, and
rheumatology at Yale before joining the Jefferson
faculty in 1982. His research concerned the cellular
actions and interactions associated with delayed
hypersensitivity. In addition, he has actively
engaged in teaching and patient care at the
Jefferson Arthritis Center and Hospital.
Volunteer physicians have also made important
contributions to the Division. Dr. John R.
Patterson (Jefferson, 1959) joined the Division as a
part-time member in 1961. After completion of a
residency in internal medicine at Jefferson, during
which he devoted nine months to training in
rheumatology, Dr. Patterson limited his practice
to the subspeciality of rheumatology. In addition
to teaching at the arthritis clinic, he attended the
sarcoid clinic directed by Dr. Harold Israel. The
sarcoid clinic provided Dr. Patterson with a
unique opportunity to evaluate and classify
rheumatic disease among a large group of patients
with sarcoidosis.
Dr. Ronald Restifo, a graduate of the Indiana
University School of Medicine, who had been a
fellow and staff physician in the section of
rheumatology at the University of Pennsylvania
Hospital, joined the Division in 1967. While at
Jefferson he attended the arthritis clinic,
maintained an office at the Mohler building, and
was also active at Jefferson Hospital. A capable
clinician and teacher, Dr. Restifo was popular
with students, house staff, and colleagues. The call
of the West proved irresistible, however, and
Restifo left Jefferson in 1972 to enter private
practice in San Jose, Calif(xma.

A Fellowship Program was established in the
Division in 1968. The first trainees were Drs.
Walter Schwarzchild and Vincent Giuliano, both
going on to the practice of rheumatology.
Subsequent early Fellows varied in their pursuits
with respect to practice and research. As the
Division gained strength, research became more
intense and innovative. Dr. Anthony Cuccinotta
investigated bone density in patients with
rheumatic disease. Dr. Muhammed Sadeghian, a
graduate of the University of Teheran, worked
with Dr. Abruzzo in the evaluation of piroxicam,
a nonsteroidal antiinflanunatOlY drug. Sadeghian
has continued investigations in Iran, including the
possible value of colchicine in the management of
calcinosis universalis.
In 1982 the Fellowship Program was expanded
so that a trainee was accepted every year rather
than every two years. This format permitted the
first-year fellow to concentrate on clinical
activities and the second year Fellow to devote his
or her efforts to a research project. Dr. Lawrence
Brent (Jefferson, 1978) became the first Fellow
under the two-year program. His studies on 1'
lymphocytes in normal mice stimulated him to
pursue further training in the field of immunology
at the University of Alabama. Dr. Bruce Bender
(Jefferson, 1977) studied monoclonal antibodies
with specificity for HLA-DR antigens. Dr. John
Fort studied the occurrence of anticardiolipin
antibodies in various connective tissue diseases
during his Fellowship, then joined the Jefferson
full-time faculty to continue research, teaching,
and patient care activities. The Division accepted
its first woman Fellow in 1985, Dr. Celia
Fernandez, from the Rutgers University School of
Medicine.
Jefferson's history of rheumatology is replete
with contributions in literature, teaching and
patient care. During the 1980s, successors to its
pioneer rheumatologists required an environment
supportive of research for full-time investigators
with relatively light teaching and patient care
responsibilities. To this end Dean Joseph Gonnella
and Professors Willis Maddrey, Darwin Prockop,
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and Jouni Uitto recruited a group of new faculty
members: Drs. Sergio Jimenez, John Varga, and
Reza Bashey. This trio provided research skills for
the rheumatology program as well as for other
departments engaged in the comprehensive study
of collagen and diseases marked by coUagen
defects and progressive fibrosis. These newcomers
are ranked along with Cornile LeRoy and his co
workers at the Medical University of South
Carolina as the two groups most productive in the
investigation of scleroderma in the United States.
Dr. Jimenez and his colleagues joined other
newcomers to Jefferson, Drs. Prockop
(Biochemistry), Emanuel Rubin (Pathology),
Maddrey (Medicine), and Uitto (Dermatology) for
a multilateral approach to the diseases of
connective tissue, particularly the collagen
component. Specific diseases studied include
osteoarthritis, osteogenesis imperfecta, and those
associated with progressive fibrosis such as
scleroderma and hepatic cirrhosis.
Dr. Sergio Jimenez, a native of Peru, received
his early training there (M.D., University of San
Marcos, 1964, magna cum laude). Following
internship in Lima, he came to the United States
for training in internal medicine on the University
of Pennsylvania service at Philadelphia General
Hospital and later at the Mayo Clinic, returning
to Philadelphia General Hospital as a Research
Fellow under Dr. Darwin Prockop at the Clinical
Research Center. Numerous publications followed
relative to the molecular structure, biochemistry,
synthesis, and genetic regulation of collagen.
Jimenez was appointed to a Rheumatology
Fellowship under Dr. ALlen Myers at the
University of Pennsylvania School of Medicine
and joined the teaching staff as Associate in
Medicine in 1973. He advanced to full Professor in
the Departments of Medicine and Orthopedic
Surgery. In 1987 he was appointed Professor of
Medicine and Director of Rheumatology Research
at Jefferson, thus rejoining his early mentor, Dr.
Prockop, who had come to Jefferson in 1986 as
Chairman of Biochemistry and Director of the
Jefferson Institute of Molecular Medicine.

Dr. Jimenez has published more than TOO papers
and has received numerous awards including the
Gerald Rodnan Award for excellence in
scleroderma research.
Dr. Jolm Varga (New York University School
of Medicine, 1980) was trained in internal
medicine at Rhode Island Hospital. This was
followed by a Fellowship in rheumatology under
Dr. Alan Cohen at Boston University and a
postdoctoral fellowship at the University of
Pennsylvania, where he joined Dr. Jimenez in the
study of collagen. Dr. Varga has studied
specifically amyloidosis and scleroderma. His
publications include chapters in three textbooks.
Dr. Reza Bashey was educated at the University
of Bombay (1952). He remained there for his
M.S. in biochemistry and then went on to Rutgers
for his Ph.D. His collagen research began at the
University of Southern California and at the
University of Miami, after which he had
appointments at Albert Einstein College of
Medicine in New York and at Hahnemann
University, Philadelphia. In 1975 Bashey was
appointed a senior investigator at the Philadelphia
General Hospital Clinical Research Center, where
he joined Dr. Jimenez and held Associate status in
the Department of Medicine at the University of
Pennsylvania. He continued at Pennsylvania, with
appointments in both the Schools of Medicine and
Dentistry, until he joined the Jefferson Faculty as
Research Associate Professor of Medicine in 1987.
These recent research capabilities promise
improvements in our knowledge of the etiology of
rheumatic diseases, with the possibility of better
methods of treatment while at the same time
aiding in a more comprehensive understanding of
disease in its global relationships.
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